S10 Ep46: Midweek Takeaway featuring Tim McCarthy, CEO, and Dr Sébastien Goudreau, newly appointed CSO of ImmuPharma #IMM
In this episode of the Midweek Takeaway, we’re joined by Tim McCarthy, CEO, and Dr Sébastien Goudreau, newly appointed CSO of ImmuPharma. The company has just announced a groundbreaking patent for its lead asset P140, the world’s first “Immunormalizer,” offering a precision diagnostic and treatment approach for autoimmune diseases. With potential 20-year exclusivity, the patent targets patients with the newly identified “Type M” immune disorder, who are super-responders to P140, opening the door to safer, more effective therapies across up to 50 autoimmune conditions. We discuss how this dual…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.